All articles by Jennifer Newton – Page 7
-
Business
AstraZeneca to buy Acerta for blood cancer drug
Deal will strengthen AstraZeneca’s immunotherapy offering
-
Business
Mexico approves world’s first dengue vaccine
Sanofi’s vaccine protects children and adults against the mosquito-borne disease
-
Business
Pfizer to close Cambridge pain outpost
120 jobs under threat from closure of Neusentis subsidiary R&D site
-
Research
Molecular legacy of Antoni Gaudi
Iconic architect’s sphere of influence extends into chemistry
-
Research
Waste not, want not?
Exclusive interview with Karen Wilson, research director at the European Bioenergy Research Institute
-
Research
Synthetic stomach membrane to minimise animal tests
Researchers strive to replace lab animals with hydrogel models
-
Research
Molecular Sierpinski triangles get stability upgrade
Another research team have fun with fractals
-
Business
No one should be denied medication
Exclusive interview with Yusuf Hamied, chairman of Indian generic drugmaker Cipla
-
Feature
More than dirty snowballs?
Comets are thought to represent leftover building blocks of the solar system; Jennifer Newton finds more questions than answers
-
Research
Chemists snare 17-electron half-sandwich radical
Important organometallic complex finally isolated and characterised after 40-year pursuit
-
Research
Defective by design
Structural disorder brings out desirable but counterintuitive phenomenon in metal–organic framework
-
Research
Group 12 members unite in unusual bonding situation
Unique complex contains first instance of bonding between zinc and mercury
-
Research
Graphene looks to doped superbenzene to overcome electronic hurdles
Carefully designed jigsaw pieces may provide solution to graphene bandgap difficulties